SS Innovations International Reports Director/Officer Changes & Financials
Ticker: SSII · Form: 8-K · Filed: Sep 26, 2025 · CIK: 1676163
Sentiment: neutral
Topics: management-change, financials, corporate-governance
TL;DR
SS Innovations International is shuffling its board and exec team, plus filing financials. Big changes afoot.
AI Summary
SS Innovations International, Inc. filed an 8-K on September 26, 2025, reporting on the departure of directors, election of new directors, appointment of officers, and compensatory arrangements. The filing also includes financial statements and exhibits, with the earliest event reported being September 24, 2025. The company was formerly known as AVRA Medical Robotics, Inc. until June 1, 2016.
Why It Matters
This filing indicates significant changes in the company's leadership and governance structure, which could impact its strategic direction and operational execution.
Risk Assessment
Risk Level: medium — Changes in directors and officers, along with the filing of financial statements, can signal shifts in company strategy or performance that warrant closer examination.
Key Players & Entities
- SS Innovations International, Inc. (company) — Registrant
- AVRA Medical Robotics, Inc. (company) — Former company name
- September 24, 2025 (date) — Earliest event reported
- September 26, 2025 (date) — Filing date
- June 1, 2016 (date) — Date of name change
FAQ
Who are the departing directors or officers?
The filing indicates the departure of directors or certain officers but does not name them in the provided text.
Who are the newly elected directors or appointed officers?
The filing mentions the election of directors and appointment of officers but does not provide specific names in the excerpt.
What are the details of the compensatory arrangements for the officers?
The filing notes compensatory arrangements of certain officers as an item reported, but the specific details are not included in the provided text.
What is the significance of the financial statements being filed?
The filing includes financial statements and exhibits, suggesting a reporting of the company's financial condition and performance.
When did SS Innovations International, Inc. change its name from AVRA Medical Robotics, Inc.?
The company changed its name from AVRA Medical Robotics, Inc. on June 1, 2016.
Filing Stats: 845 words · 3 min read · ~3 pages · Grade level 11.8 · Accepted 2025-09-26 08:30:36
Key Financial Figures
- $163,000 — a base annual salary of approximately US$163,000 (based on current Indian rupee to U.S.
Filing Documents
- ea0258851-8k_ssinnov.htm (8-K) — 28KB
- ea025885101ex10-1_ssinnov.htm (EX-10.1) — 113KB
- ea025885101ex99-1_ssinnov.htm (EX-99.1) — 12KB
- ex10-1_001.jpg (GRAPHIC) — 10KB
- ex99-1_001.jpg (GRAPHIC) — 12KB
- 0001213900-25-091939.txt ( ) — 379KB
- ssii-20250924.xsd (EX-101.SCH) — 3KB
- ssii-20250924_lab.xml (EX-101.LAB) — 33KB
- ssii-20250924_pre.xml (EX-101.PRE) — 22KB
- ea0258851-8k_ssinnov_htm.xml (XML) — 4KB
02 Departure of Directors or Certain Officers; Election of
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On September 26, 2025, we issued a press release announcing that effective September 24, 2025, Naveen Kumar Amar joined the Company as its Chief Financial Officer. A copy of the press release is attached as Exhibit 99.1 to this Current Report and is incorporated herein by reference. Mr. Amar, 49, has over 27 years' experience in all aspects of global corporate finance, including accounting management, audits, capital raises, compliance, taxation, mergers and acquisitions and investor relations. From July 2022 until joining the Company, Mr. Amar provided remote chief financial officer services from his base in New Delhi to companies in the United States, the United Kingdom and elsewhere abroad. From March 2021 to July 2022, Mr. Amar was Head – Finance & Commercial and Senior Vice President of SpiceExpress, the cargo unit of SpiceJet Ltd., an Indian low-cost airline, where he led a team of 85 responsible for finance and accounts, cargo and commercial operations, legal and compliance and other aspects of the unit's operations. From May 2019 to June 2020, he was Global Chief Financial Officer for Munchado India, an integrated software technology enterprise provider for restaurants in the United States, Europe and India. From May 2012 to October 2018, Mr. Amar was Senior Vice President – Finance, Compliance & Company Secretary of MSD Wellcome Trust Hilleman Laboratories Pvt Ltd., a United States/United Kingdom joint venture based in India, which was engaged in the manufacture of vaccines for worldwide distribution. Other positions occupied by Mr. Kumar include Chief Financial Officer – India and Australia and Company Secretary for EDirect Proprietary Ltd., an telecommunications provider from November 2008 to January 2012 and India Manager – Financial Consolidation and Company Secretary for GE India from July 2007
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 10.1 Employment Agreement between SS Innovations International, Inc. and Naveen Kumar Amar 99.1 Press Release, dated September 26, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 1
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: September 26, 2025 SS INNOVATIONS INTERNATIONAL, INC. By: /s/ Sudhir Srivastava Sudhir Srivastava, M.D. Chairman and Chief Executive Officer 2